[D66] [JD: 174] C-19 Pandemia: Quo vadis, homo sapiens?

[R.O.]

geertvandenbossche.org
<https://www.geertvandenbossche.org/post/c-19-pandemia-quo-vadis-homo-sapiens>



  C-19 Pandemia: Quo vadis, homo sapiens?

34-43 minutes
------------------------------------------------------------------------

*1. Summary:*

The WHO’s mass vaccination program has been installed in response to a
/public health emergency of international concern/. As of the early days
of the mass vaccination campaigns, at least a few experts have been
warning against the catastrophic impact such a program could have on
global and individual health. Mass vaccination in the middle of a
pandemic is prone to promoting selection and adaptation of immune escape
variants that are featured by increasing infectiousness and resistance
to spike protein (S)-directed antibodies (Abs), thereby diminishing
protection in vaccinees and threatening the unvaccinated. This already
explains why_the WHO’s mass vaccination program is not only unable to
generate herd immunity (HI) but even leads to substantial erosion of the
population’s immune protective capacity._ As the ongoing universal mass
vaccination program will soon promote dominant propagation of highly
infectious, neutralization escape mutants (i.e., so-called ‘S
Ab-resistant variants’), naturally acquired, or vaccinal neutralizing
Abs, will, indeed, no longer offer any protection to immunized
individuals whereas high infectious pressure will continue to suppress
the innate immune defense system of the nonvaccinated. This is to say
that every further increase in vaccine coverage rates will further
contribute to forcing the virus into resistance to neutralizing,
S-specific Abs. Increased viral infectivity, combined with evasion from
antiviral immunity, will inevitably result in an additional toll taken
on human health and human lives. Immediate action needs, therefore, to
be taken in order to dramatically reduce viral infectivity rates and to
prevent selected immune escape variants from rapidly spreading through
the entire population, whether vaccinated or not.*This first critical
step can only be achieved by calling an immediate halt to the mass
vaccination program and replacing it by widespread use of antiviral
chemoprophylactics while dedicating massive public health resources to
scaling early multidrug treaments of Covid-19 disease. *


[...]



Geert Vanden Bossche (DVM, PhD)

Geert Vanden Bossche received his DVM from the University of Ghent,
Belgium, and his PhD degree in Virology from the University of
Hohenheim, Germany. He held adjunct faculty appointments at universities
in Belgium and Germany. After his career in Academia, Geert joined
several vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay
Biologicals) to serve various roles in vaccine R&D as well as in late
vaccine development. Geert then moved on to join the Bill & Melinda
Gates Foundation’s Global Health Discovery team in Seattle (USA) as
Senior Program Officer; he then worked with the Global Alliance for
Vaccines and Immunization (GAVI) in Geneva as Senior Ebola Program
Manager. At GAVI he tracked efforts to develop an Ebola vaccine. He also
represented GAVI in fora with other partners, including WHO, to review
progress on the fight against Ebola and to build plans for global
pandemic preparedness. Back in 2015, Geert scrutinized and questioned
the safety of the Ebola vaccine that was used in ring vaccination trials
conducted by WHO in Guinea. His critical scientific analysis and report
<https://37b32f5a-6ed9-4d6d-b3e1-5ec648ad9ed9.filesusr.com/ugd/28d8fe_485cd4e01c4f41219253ff69cd8d761e.pdf>
on the data published by WHO in the Lancet
<https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)61117-5/fulltext>
in 2015 was sent to all international health and regulatory
authorities involved in the Ebola vaccination program. After working for
GAVI, Geert joined the German Center for Infection Research in Cologne
as Head of the Vaccine Development Office. He is at present primarily
serving as a Biotech/ Vaccine consultant while also conducting his own
research on Natural Killer cell-based vaccines.

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://www.tuxtown.net/pipermail/d66/attachments/20210815/5214b19f/attachment.html>